Pharmafile Logo
Pharmafocus logo
Advanced Search
800px-uc-berkeley-campus-overview-from-hills

GSK sets up new CRISPR lab with UC, Berkeley

June 13, 2019
Medical Communications GSK, UC, berkely, crispr, genetics, pharma

GSK has struck a $67 million deal with the University of California, Berkeley. British multinational GlaxoSmithKline will collaborate with UC, …

News
dr_aiden_cottrell

GSK tech exec joins Institute of Cancer Research

June 13, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Institute of Cancer Research (ICR) has said GlaxoSmithKline’s Dr Adrian Cottrell will join as the institute’s new Chief Information …

Appointment
5204602349_c87b204860_z

Catalyst Pharma sues FDA after agency approves Jacobus’ LEMS drug

June 13, 2019
Business Services, Manufacturing and Production FDA, Jacobus, catalyst, firdapse, pharma, ruzurgi

Florida firm Catalyst Pharmaceuticals is suing the FDA after the agency approved a rival’s drug. The lawsuit alleges the approval …

News
genentech_web

FDA offer priority review for Genentech’s Rituxan in children

June 13, 2019
Research and Development

The FDA will offer priority review to Genentech’s supplemental biologics-license application (sBLA) application for Rituxan for children with two rare …

News
sobi_offices

Sobi acquire Novimmune in deal worth more than £400 million

June 13, 2019
Business Services, Research and Development R&D, emapalumab, immuno-oncology, immunology, pharma

Swedish rare disease specialist Sobi has agreed to buy Swiss firm Novimmune ion a deal worth more than £400 million. …

News

J&J and Colgate pay $4.8 million each to woman in California

June 13, 2019
Business Services, Medical Communications Cancer, J&J, JJ, lawsuit, pharma, talc

A California court has said Johnson & Johnson and Colgate-Palmolive must pay a total of nearly $10 million to a …

News
cq5dam

AstraZeneca spends more than twice as much as expected on new HQ

June 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, UK, headquarters, pascal soriot, pharma

AstraZeneca’s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of £330 million that …

News

Fewer opioids prescribed in states with medical marijuana, research shows

June 12, 2019
Research and Development Marijuana, medicinal cannabis, opioids, pharma

Fewer opioids are prescribed in states with legal medical marijuana, according to research from University of Texas Medical Branch at …

News

J&J ‘worse’ than Purdue Pharma expert witness says

June 12, 2019
Research and Development J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, phamra

The role Johnson & Johnson played in the opioid crisis was ‘in some ways worse’ than that of Purdue Pharma, …

News

Novo Nordisk’s oral diabetes drug safe and effective

June 12, 2019
Research and Development GLP-1, Novo Nordisk, diabetes, pharma, samgalutide

Novo Nordisk’s oral diabetes drug semaglutide is safe for those at high risk of cardiovascular complications, according to the results …

News
4108927566_c42e335fbd_z

First case of Ebola recorded in Uganda

June 12, 2019
Research and Development

Ebola has spread to Uganda, according to the WHO. A five year old boy has been infected with the Ebola …

News
vertex-headquarters

MPs discuss breaking Vertex’s IP rights to bring Orkambi to UK

June 11, 2019
Research and Development Orkambi, Vertex, access, house of commons, pharma, pricing

MPs yesterday discussed circumventing Vertex’s patent on cystic fibrosis medicine Orkambi (Lumacaftor/ivacaftor) as a means of breaking the deadlock and …

News
astrazeneca_building_white

AstraZeneca’s Phase 3 Farxiga data impresses in type 2 diabetes

June 11, 2019
Manufacturing and Production, Research and Development AstraZeneca, diabetes, farxiga, pharma, type 2 diabetes

AstraZeneca has presented new Phase 3 data at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco on …

News
lilly_building_with_american_flag_web

Eli Lilly’s heart drug underwhelms with REWIND trial

June 11, 2019
Manufacturing and Production Eli Lilly, Trulicity, pharma

Eli Lilly’s Trulicity (dulaglutide) reduced major cardiovascular events (MACE) by 12% versus placebo in adults with type 2 diabetes, according …

News
inside_aryogen

Three workers killed by explosion at pharma factory in India

June 11, 2019
Manufacturing and Production China, India, explosion, manufacturing, pharma

Three engineers have been killed in an explosion at a manufacturing facility in India. Two Chinese engineers and one Indian …

News

Roche scores FDA approval for Polivy combo in diffuse large B-cell lymphoma

June 11, 2019
Manufacturing and Production, Sales and Marketing Polivy, Roche, lymphoma, pharma

Roche is celebrating the decision taken by the FDA to approve its anti-CD79b antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) in combination …

News

Insys Therapeutics files for bankruptcy

June 11, 2019
Manufacturing and Production DoJ, Subsys, bankruptcy, insys, pharma

Opioid drugmaker Insys Therapeutics has filed for Chapter 11 bankruptcy protection after agreeing to pay $225 million to settle charges …

News
paul-hudson-big-image

Novartis Pharma head to become new Sanofi CEO

June 10, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Paul Hudson, appointment, olivier brandicourt

French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with …

Appointment
shutterstock_273326141

MSD scoops up biopharma firm Tilos for $773 million

June 10, 2019
Sales and Marketing MSD, Tilos Therapeutics, acquisition, pharma

US-based firm MSD has announced it intends to acquire biopharma firm Tilos Therapeutics, and has signed a deal with the …

News

Sanofi’s Soliqua proves superior to GLP-1 RA therapies in reducing blood sugar levels

June 10, 2019
Research and Development, Sales and Marketing Sanofi, Soliqua, diabetes, pharma, type 2 diabetes

Sanofi has stepped up at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco, revealing new data which …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026